Invention Grant
- Patent Title: Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases
-
Application No.: US17505672Application Date: 2021-10-20
-
Publication No.: US12110335B2Publication Date: 2024-10-08
- Inventor: Peter Michael Benz , Remko Alexander Bakker , Holger Fuchs , Fei Han , Sandeep Kumar , Sarah Low , Justin M. Scheer , Leo Thomas
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Mary Breen Smith
- Priority: EP 203030 2020.10.21
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00 ; A61P27/02 ; C07K16/22
Abstract:
This invention relates to binding molecules that bind specifically Vascular Endothelial Growth Factor (VEGF) and Tropomyosin receptor kinase B (TrkB) and their use in medicine, pharmaceutical compositions comprising the same, and methods of using the same as agents for treatment and/or prevention of diseases of the eye.
Public/Granted literature
- US20220119535A1 BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATMENT OF EYE DISEASES Public/Granted day:2022-04-21
Information query
